Outsourced Pharma Capacity Update Videos - Small Molecule
-
Rottendorf Pharma Capabilities Update October 2026: Small Molecule Drug Product
11/3/2026
Optimize oral solid dose development with scalable formulations, robust process engineering, and integrated supply networks that accelerate scale-up and ensure reliable market delivery.
-
Morpho Alfasigma Capabilities Update October 2026: Small Molecule Drug Product
11/3/2026
Scale-up small molecule therapies with seamless tech transfer, regulatory alignment, and commercial manufacturing expertise for reliable, high-quality drug delivery.
-
Novartis Capabilities Update October 2026: Small Molecule Drug Substance
11/3/2026
Scaling small molecule production demands flexible capacity, specialized chemistry, and seamless tech transfer. High-containment manufacturing supports reliable supply from clinic to commercial.
-
Bora Pharmaceuticals Capabilities Update October 2026: Small Molecule Drug Product
11/3/2026
Simplify outsourcing across diverse pipelines with flexible dosage-form capabilities, scalable capacity, and support from clinical development to commercial supply.
-
SK Pharmteco Capabilities Update October 2026: Small Molecule Drug Substance
11/3/2026
Backed by decades of experience and a proven track record of quality, this organization deliver programs from early-phase to commercial manufacturing.
-
Siegfried Capabilities Update October 2026: Small Molecule Drug Substance
11/3/2026
Siegfried supports small molecules from development through commercialization with scalable processes and a global network built for reliable, secure supply.
-
Flamma Capabilities Update October 2026: Small Molecule Drug Substance
11/3/2026
Discover how new approaches to API and peptide development can improve process control, repeatability, efficiency, and manufacturing readiness.
-
Upperton Pharma Solutions Capabilities Update April 2026: Small Molecule Drug Product
4/28/2026
Learn more about UK-CDMO, Upperton Pharma Solutions, and their expertise across oral, nasal, pulmonary and sterile drug product development and manufacturing
-
Thermo Fisher Scientific Capabilities Update April 2026: Small Molecule Drug Product
4/28/2026
Align formulation, process, and scale strategy early to support larger batches, new equipment, and commercial manufacturing — cutting rework and speeding Phase I to launch.
-
From Formulation To Commercial Supply: Advancing Small Molecule Therapies
4/28/2026
We assist pharmaceutical and biotechnology companies with their contract manufacturing and development needs, specializing in high-potency softgels and liquids.